CLINICAL_TRIALS
research
· 2026-04-09
Clinical Trial Update: WATCHMAN FLX Pro European Registry [NA]
Summary
The WATCHMAN FLX Pro European Registry is currently recruiting to study left atrial appendage closure in patients with non-valvular atrial fibrillation. The reg…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Boston Scientific Corporation | Conditions: Non-valvular Atrial Fibrillation (AF), Left Atrial Appendage Closure | NA | Status: RECRUITING